P063: Assessment of neuroinflammatory changes in chronic pain patients under spinal cord stimulation

FAU own research funding: EFI / IZKF / EAM ...


Start date : 01.09.2020

End date : 31.08.2021

Extension date: 31.07.2024


Project details

Scientific Abstract

Clinical and animal studies implicate neuroinflammatory features (interleukines, chemokines, adipokines, oxytocin, alarmins) as part of the pathophysiology. BurstDR-SCS and DRG-SCS stimulation present a paradigm shift in current neurostimulation to address the treatment of CPSP-associated pain. Such molecular analysis may underpin the emerging role of CPSP-related molecular patterns as potential biomarkers to reliably reproduce spinal stimulation effects.

Involved:

Contributing FAU Organisations:

Research Areas